Integrated Biopharma Executives
Integrated Biopharma employs about 147 people. The company is managed by 9 executives with a total tenure of roughly 38 years, averaging almost 4.0 years of service per executive, having 16.33 employees per reported executive. Discussion of Integrated Biopharma's management performance can provide insight into the enterprise performance.
| Gerald Kay Chairman Chairman, CEO and Pres |
| Riva Sheppard President Executive Vice President Director |
Integrated |
Integrated Biopharma Management Team Effectiveness
The company has return on total asset (ROA) of 0.0336 % which means that it generated a profit of $0.0336 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1268 %, meaning that it created $0.1268 on every $100 dollars invested by stockholders. Integrated Biopharma's management efficiency ratios could be used to measure how well Integrated Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.Integrated Biopharma Workforce Comparison
Integrated Biopharma is rated third overall in number of employees category among its peers. The total workforce of Consumer Staples industry is currently estimated at about 33,520. Integrated Biopharma adds roughly 147 in number of employees claiming only tiny portion of stocks in Consumer Staples industry.
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03. Integrated Biopharma Notable Stakeholders
An Integrated Biopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Integrated Biopharma often face trade-offs trying to please all of them. Integrated Biopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Integrated Biopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gerald Kay | Chairman, CEO and Pres | Profile | |
| Riva Sheppard | Executive Vice President Director | Profile | |
| Dina Masi | CFO, Sr. VP and Secretary | Profile | |
| Christina Kay | Executive VP and Director | Profile | |
| Schild OBE | Chief iBioPharma | Profile | |
| Nickolas Palin | Pres Segment | Profile | |
| Robert Erwin | Pres iBioPharma | Profile | |
| Jamie Levey | Head Relations | Profile | |
| Orn Adalsteinsson | Chief Inc | Profile |
Integrated Biopharma Workforce Analysis
Traditionally, organizations such as Integrated Biopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Integrated Biopharma within its industry.Integrated Biopharma Manpower Efficiency
Return on Integrated Biopharma Manpower
| Revenue Per Employee | 382.6K | |
| Revenue Per Executive | 6.2M | |
| Net Income Per Employee | 26.1K | |
| Net Income Per Executive | 426.4K | |
| Working Capital Per Employee | 6.2K | |
| Working Capital Per Executive | 101.4K |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Integrated OTC Stock
If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |